Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP1075 | DOI: 10.1530/endoabs.90.EP1075

ECE2023 Eposter Presentations Thyroid (128 abstracts)

A vesicular carcinoma of the thyroid on Graves’ disease: a rare association

Chaymaa Alami Hassani 1 , Ayoub Idrissi 2 , Abainou Lahousssaine 2 , Sanae Elhadri 2 , Azzelarab Meftah 2,3 & Hicham Baizri 3,4


1CHU SOUSS MASSA AGADIR/Faculty of Medicine and Pharmacy Ibn Zohr Agadir, Department of Endocrinology Diabetology and Metabolic Diseases, Agadir, Morocco, 2Military Hospital Avicenne Marrakech, Department of Endocrinology Diabetology and Metabolic Diseases, Marrakech, Morocco, 3Faculty of Medicine and Pharmacy - CADI AYYAD University Marrakech, Marrakech, Morocco, 2Military Hospital Avicenne Marrakech, Department of Endocrinology Diabetology and Metabolic Diseases, Marrakech, Morocco


Introduction: The occurrence of vesicular carcinoma in Graves’ disease is exceptional. It is most often a papillary carcinoma rarely vesicular. We report the case of a vesicular carcinoma discovered at the anatomopathological study of a total thyroidectomy in a patient followed for Graves’ disease.

Observation: This is a 61-year-old female patient with type 2 diabetes, on SGLT2 inhibitor. There isn’t any family history of thyroid cancer or exposure to radiation in the cervico-thoracic region. Consulted for pelvic girdle myopathy with thyrotoxicosis. The biological assessment showed a TSH of 00 uUI/ml, an LT4 elevated twice the normal value, positive anti TSH receptor antibodies at 21 IU/l, and on ultrasound a thyroiditis appearance with a left lower lobar nodule 3 of 20.4*24.3*22 mm classified EUTIRADS 3 and a right lower lobar nodule of 10.2*6.3 mm classified EUTIRADS 3. Thyroid scintigraphy showed an aspect in favour of Graves’ disease associated with a hypo-captant left lower lobar nodule. The patient received synthetic antithyroid drugs until euthyroidism was obtained, then she underwent a total thyroidectomy\. Histology concluded to a vesicular micro carcinoma of the thyroid of 7mm in diameter with capsular breakthrough and without vascular emboli. The patient did not receive iodine 131, simple monitoring with L-thyroxine inhibitor treatment were indicated.

Conclusion: The association of Graves’ disease and vesicular carcinoma remains rare but the discovery of a thyroid nodule during surveillance or even at diagnosis constitutes a predictive element requiring a careful search for malignancy as illustrated by our clinical case.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

Sean P Cleary (<1 min ago)
Ekaterina Zaikova (<1 min ago)
Olga Gadjieva (<1 min ago)
B (<1 min ago)
Parichat Yimnoi (<1 min ago)